APA

Hebart H., Rauser G., Stevanovic S., Haenle C., Nussbaum A. K., Meisner C., Bissinger A. L., Tenzer S., Jahn G., Loeffler J., Rammensee H., Schild H. & Einsele H. (20031118). A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation. : Experimental hematology.

Chicago

Hebart Holger, Rauser Georg, Stevanovic Stefan, Haenle Claire, Nussbaum Alexander K, Meisner Christoph, Bissinger Alfred L, Tenzer Stefan, Jahn Gerhard, Loeffler Juergen, Rammensee Hans-Georg, Schild Hansjörg and Einsele Hermann. 20031118. A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation. : Experimental hematology.

Harvard

Hebart H., Rauser G., Stevanovic S., Haenle C., Nussbaum A. K., Meisner C., Bissinger A. L., Tenzer S., Jahn G., Loeffler J., Rammensee H., Schild H. and Einsele H. (20031118). A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation. : Experimental hematology.

MLA

Hebart Holger, Rauser Georg, Stevanovic Stefan, Haenle Claire, Nussbaum Alexander K, Meisner Christoph, Bissinger Alfred L, Tenzer Stefan, Jahn Gerhard, Loeffler Juergen, Rammensee Hans-Georg, Schild Hansjörg and Einsele Hermann. A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation. : Experimental hematology. 20031118.